May & Baker Nigeria Plc

May & Baker Nigeria Plc is a pioneering pharmaceutical company, established on September 4, 1944, as Nigeria’s first pharmaceutical manufacturer. It originated from the British firm Grimwade, May & Pickett, founded in 1834, which evolved into May & Baker UK Limited. The Nigerian subsidiary began as a trading outpost and has since grown into a leading healthcare company.

Business Operations

The company operates through two main business units: Pharmaceuticals and Beverages. Its product portfolio includes a wide range of pharmaceuticals such as anti-diabetics, anti-infectives, anti-malaria drugs, analgesics, cough and cold remedies, multivitamins, and anxiolytics. In the beverage sector, it produces bottled water under the Lily Water brand and other consumer products.

Subsidiaries and Partnerships

May & Baker Nigeria Plc has four subsidiaries:

• Biovaccines Nigeria Limited: A partnership with the Federal Government for local vaccine production.
• Osworth Nigeria Limited, Servisure Nigeria Limited, and Tydipacks Nigeria Limited: These subsidiaries focus on various aspects of healthcare and consumer products.

Financial Performance

In the financial year ending December 31, 2023, the company reported a revenue of ₦19.70 billion and a net profit of ₦1.08 billion, reflecting strong growth and operational efficiency.

Commitment to Quality and Innovation

With over eight decades in the industry, May & Baker Nigeria Plc has maintained a reputation for quality and innovation. The company adheres to rigorous quality assurance procedures and current Good Manufacturing Practices (cGMP) to ensure the efficacy and safety of its products.